Exemptia 40 Mg Adalimumab Injection

Name: Exemptia 40 Mg Adalimumab Injection
Brand: MEDICINE PLANET

Get a Price/Quote

MOQ : 5 Vials

Exemptia 40 Mg Adalimumab Injection Specification

Indication
Ulcerative Colitis, Ankylosing Spondylitis, Crohns Disease

Salt Composition
Adalimumab 40 mg

Dosage Form
Injection

Feature
Pre-filled syringe

Ingredients
Adalimumab

Application
Immunosuppressive Therapy

Physical Color/Texture
Clear solution

Storage Instructions
Refrigerate, Do not freeze

Shelf Life
As per pack information

Box Color
White & Pink

Prescription
Required

Strength
40mg/0.8ml

Intended Users
Adults

Type
Monoclonal antibody

Storage Temp
2-8C

Administration Route
Subcutaneous

Packaging Size
1X1

Exemptia 40 Mg Adalimumab Injection Trade Information

Minimum Order Quantity
5 Vials

Supply Ability
100 Vials Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Exemptia 40 Mg Adalimumab Injection

Exemptia 40 Mg Adalimumab Injection is a must-have, first-string choice for adults seeking outstanding immunosuppressive therapy. Acclaimed for its effectiveness, this prescription monoclonal antibody is expertly formulated to target complex conditions like Crohn's Disease, Ulcerative Colitis, and Ankylosing Spondylitis. Presented in a premium pre-filled syringe with a user-friendly design, this product offers the perfect combination of reliability and convenience. With each purchase, you receive a high-quality, clear solution, safely stored in an elegant white & pink box-making it the preferred selection for both patients and healthcare providers.

Exceptional Usage & Applications of Exemptia 40 Mg Adalimumab Injection

Exemptia 40 Mg Adalimumab Injection is designed for adults who require advanced immunosuppressive therapy in the management of autoimmune diseases such as Ulcerative Colitis, Crohn's Disease, and Ankylosing Spondylitis. The injection is administered subcutaneously and features a ready-to-use pre-filled syringe for ease of use. Its outstanding efficacy and clear solution form ensure a dependable treatment experience under professional supervision, making it perfect for regular hospital and clinical applications.

Order Completion, Payment Terms & Premium Supply Ability

Experience smooth order completion and competitive payment terms when sourcing Exemptia 40 Mg Adalimumab Injection. Our manufacturer, exporter, and supplier capabilities from India ensure premium supply ability and consistent delivery to the global export market. Sample policy options are available for eligible buyers, and payment processes are streamlined for efficiency. Partner with us to guarantee trusted sourcing of this indispensable immunosuppressive injection with assured quality and shipment fulfillment.

FAQ's of Exemptia 40 Mg Adalimumab Injection:

Q: How is Exemptia 40 Mg Adalimumab Injection administered?

A: Exemptia 40 Mg Adalimumab Injection is administered subcutaneously, typically under the supervision of a healthcare professional. The convenient pre-filled syringe design makes it easy and safe to use.

Q: What are the main indications for using Exemptia 40 Mg Adalimumab Injection?

A: This injection is primarily indicated for adults managing autoimmune conditions such as Ulcerative Colitis, Crohn's Disease, and Ankylosing Spondylitis. It acts as an immunosuppressive therapy to help control inflammation.

Q: When should Exemptia 40 Mg Adalimumab Injection be refrigerated?

A: The injection must be stored between 2-8C and placed in a refrigerator upon receipt. It is important not to freeze the product to maintain its effectiveness.

Q: Where can I purchase Exemptia 40 Mg Adalimumab Injection?

A: Exemptia 40 Mg is available through licensed suppliers, exporters, and manufacturers based in India. A valid prescription from a qualified healthcare provider is required for purchase.

Q: What is the benefit of choosing Exemptia's pre-filled syringe feature?

A: The pre-filled syringe offers enhanced convenience, accurate dosing, and minimizes risk of contamination, making administration easier and safer for patients and clinicians alike.